Event

CROI 2023

Seattle, W.A.

The Conference on Retroviruses and Opportunistic Infections (CROI) took place February 19-22 at the Summit Convention Center in Seattle. HPTN researchers presented eight abstracts covering HPTN 071, HPTN 083, HPTN 084, HPTN 084-01, and the HPTN Modelling Centre.

HPTN at CROI 2023

Population Impact of Expanding PrEP Usage in South Africa: Model Comparison Analysis – Sarah Stansfield

HIV Incidence Differences Measured by Serial Cross-Sectional Incidence Testing (HPTN 071 / PopART) – Oliver Laeyendecker

Cabotegravir Pharmacology in The Background of Delayed Injections (HPTN 084) – Mark Marzinke

The LEVI Syndrome: Characteristics of Early HIV Infection with Cabotegravir for PrEP (HPTN 083 and HPTN 084) – Susan Eshleman

Cabotegravir for HIV PrEP in U.S. Black Men and Transgender Women Who Have Sex with Men (HPTN 083) – Hyman Scott

CAB-LA for HIV Prevention in African Cisgender Female Adolescents (HPTN 084-01) – Sybil Hosek

Pre-Exposure Prophylaxis Product Choice in U.S. Participants (HPTN 083) – Meredith Clement

Bone Density Changes with CAB-LA or TDC/FTC PrEP in MSM and TGW (HPTN 083) – Todd Brown